|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies. |
| 公司地址
| 8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000 |
| 電話號碼
| +61 409840786 |
| 傳真號碼
| +61 425703805 |
| 公司網頁
| https://www.incannex.com.au |
| 員工數量
| 12 |
| Mr. Lekhram Changoer |
Chief Technology Officer |
-- |
29/09/2025 |
| Mr. Joseph Swan |
Treasurer, Principal Accounting Officer, Chief Financial Officer and Secretary |
美元 150.65K |
29/09/2025 |
| Dr. Luigi M. Barbato, M.D. |
Chief Medical Officer |
美元 264.06K |
29/09/2025 |
| Mr. Joel Latham |
Director, Chief Executive Officer and President |
美元 656.46K |
27/10/2025 |
|
|
| Dr. George E. Anastassov, M.D. |
Independent Director |
27/10/2025 |
| Mr. Joel Latham |
Director, Chief Executive Officer and President |
27/10/2025 |
| Mr. Troy Valentine |
Chairman of the Board |
27/10/2025 |
| Mr. Peter Widdows |
Independent Director |
27/10/2025 |
| Mr. Robert Clark |
Independent Director |
27/10/2025 |
|
|
|
|
